D. Levine

Clinical Infectious Diseases · 2005–2019

A researcher in the Science corpus: 6 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Whom D. Levine trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. S. Cosgrove

Who trusts D. Levine overall

  1. Eirini Christaki
  2. B. Howden

Papers from D. Levine's perspective

Ordered by how strongly the researchers D. Levine trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections (Clinical Pharmacokinetics)
  2. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of… (American Journal of Health-System Pharmacy)
  3. Staphylococcus aureus endocarditis: a consequence of medical progress. (Journal of the American Medical Association (JAMA))
  4. Methicillin-resistant S. aureus infections among patients in the emergency department. (New England Journal of Medicine)
  5. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. (Journal of the American Medical Association (JAMA))
  6. Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia (Journal of Clinical Microbiology)
  7. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. (Archives of Internal Medicine)
  8. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. (New England Journal of Medicine)
  9. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. (Circulation)
  10. Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin (Antimicrobial Agents and Chemotherapy)

Their papers